Results 161 to 170 of about 169,886 (331)
Diagnostic Performance of Combined Conventional CT Imaging Features and Radiomics Signature in Differentiating Grade 1 Tumors from Higher-Grade Pancreatic Neuroendocrine Neoplasms [PDF]
Florent Tixier +11 more
openalex +1 more source
ABSTRACT Background and Aims Contrast‐enhanced endoscopic ultrasonography (CE‐EUS) provides clearer visualization of wall layer structures in gallbladder nodules than B‐mode EUS. This study aimed to compare the diagnostic performance of B‐mode EUS and CE‐EUS in differentiating benign from malignant gallbladder lesions.
Kensaku Yoshida +7 more
wiley +1 more source
This prospective study investigated the feasibility of stabilised hyaluronic acid gel as a rectal spacer in gynaecological cancer brachytherapy. In twelve patients, the spacer was successfully inserted into the rectovaginal space without serious adverse events, had high visibility on MRI, increased the target‐to‐rectum distance compared with no spacer ...
Carminia Lapuz +8 more
wiley +1 more source
Molecular theranostics: principles, challenges and controversies
Molecular theranostics offers a powerful tool to drive precision medicine in nuclear oncology. While theranostics is not a new principle in nuclear medicine, recent advances in instrumentation and radiopharmacy have driven a reinvigoration and a broader suite of applications.
Geoffrey Currie
wiley +1 more source
ASO Author Reflections: Active Surveillance for Local Colorectal Neuroendocrine Tumors—Patient Selection is Paramount [PDF]
Benjamin C. Greenspun +4 more
openalex +1 more source
A Rare Gastric Carcinoma- Neuroendocrine Tumors
Petar Svorcan +2 more
openalex +2 more sources
Synergistic Cytotoxic Effect of a Novel mTOR/PI3K Dual Inhibitor PF-04691502 and Radiation Therapy on Neuroendocrine Tumor Cells [PDF]
Z. Chow
openalex +1 more source
ABSTRACT Tumor organoid models are revolutionizing cancer research by bridging the translational gap between conventional two‐dimensional cell cultures and animal models. This Editorial thoroughly explores the fundamental innovations of patient‐derived organoid technology.
Yimao Wu +4 more
wiley +1 more source

